Faron Pharmaceuticals Oy (LON:FARN – Get Free Report) shares passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of GBX 136.23 ($1.71) and traded as low as GBX 132 ($1.66). Faron Pharmaceuticals Oy shares last traded at GBX 145 ($1.82), with a volume of 21,592 shares traded.
Faron Pharmaceuticals Oy Price Performance
The company’s fifty day moving average price is GBX 136.23 and its 200 day moving average price is GBX 231.86. The company has a market capitalization of £99.77 million, a P/E ratio of -345.24 and a beta of -0.14. The company has a quick ratio of 1.09, a current ratio of 0.59 and a debt-to-equity ratio of 121.51.
About Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. The company's lead product candidates are Traumakine, an investigational intravenous interferon beta-1a therapy for the treatment of acute respiratory distress syndrome, COVID-19, acute kidney injury, cardiac protection, solid organ transplant, and ischemia reperfusion injury; and Bexmarilimab, a novel precision cancer immunotherapy candidate for treating solid tumors, non-small cell lung carcinoma, and hematological malignancies.
Featured Stories
- Five stocks we like better than Faron Pharmaceuticals Oy
- What is the Hang Seng index?
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Hilton Demonstrates Asset Light is Right for Investors
- What is the Shanghai Stock Exchange Composite Index?
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.
